Related Experiment Videos
Nicotine does not affect plasma lipoprotein concentrations in healthy men.
M Quensel1, C D Agardh, P Nilsson-Ehle
1Department of Internal Medicine, University of Lund, Sweden.
Summary
Nicotine gum, used for smoking cessation, did not alter lipid and lipoprotein levels in healthy volunteers. These findings suggest nicotine itself is not responsible for smoking-related metabolic changes.
Area of Science:
- Pharmacology
- Metabolic Studies
- Cardiovascular Health
Background:
- Smoking is associated with adverse changes in plasma lipid and lipoprotein metabolism.
- Nicotine is a primary component of tobacco smoke, but its specific role in these metabolic alterations is unclear.
Purpose of the Study:
- To investigate the effects of therapeutic nicotine administration via chewing gum on plasma lipid and lipoprotein concentrations.
- To determine if nicotine is the causative agent for smoking-induced metabolic changes.
Main Methods:
- Young healthy volunteers received 2 mg of nicotine chewing gum eight times daily for two weeks.
- Plasma levels of lipids (triglyceride, cholesterol, HDL cholesterol, LDL cholesterol) and apolipoproteins (AI, B) were measured.
- Activities of lipoprotein lipase and hepatic lipase were assessed in post-heparin plasma.
- Cotinine levels were monitored to confirm nicotine exposure.
Main Results:
- Nicotine metabolite (cotinine) levels reached concentrations similar to those in smokers.
- Plasma lipid, lipoprotein, and apolipoprotein concentrations remained unchanged throughout the study.
- Lipoprotein lipase and hepatic lipase activities were unaffected by nicotine gum administration.
Conclusions:
- Nicotine administration through chewing gum does not appear to affect plasma lipid and lipoprotein metabolism.
- The metabolic side effects associated with smoking are likely not mediated by nicotine alone.
- Nicotine replacement therapy using chewing gum may be a safer alternative regarding metabolic health compared to smoking.